Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
REVLON REVS INVESTORS WITH EARNINGS SURPRISE, CONTINUED MARKET LEADERSHIP BACKED BY PRODUCT INNOVATION, HEAVY ADVERTISING; STOCK CLIMBS 14.3% TO 31 IN THIRD QUARTER
Oct 07 1996
•
By
The Rose Sheet
More from Archive
More from HBW Insight